A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials

1Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Sarecycline is a novel, narrow-spectrum, third generation tetracycline class antibiotic approved by the Food and Drug Administration (FDA) for the treatment of moderate-to-severe acne in patients ages nine and older. Recently, focus has increased on whether treatment responses differ in acne in skin of color. Here, we aimed to analyze the efficacy of using sarecycline in Hispanics. We report pooled post hoc analysis of efficacy data on sarecycline in Hispanics with acne from two phase 3, multicenter, randomized, double-blind, placebo-controlled clinical trials, SC1401 and SC1402. Of 2002 patients in the pooled trials with moderate-to-severe acne, 26.9% were Hispanic. Facial inflammatory lesion counts decreased as early as week 3 by 26% (p = 0.0279), with continued reduction by 41% by week 6 (p = 0.0003), by 51% by week 9 (p < 0.0001), and by 55% by week 12 (p < 0.0001). Acne is the most common skin condition diagnosed in Hispanics, and this study illustrates a statistically significant reduction in acne in Hispanic patients with moderate-to-severe acne treated with oral sarecycline. Therefore, oral sarecycline shows promising results as a safe and effective treatment for acne in Hispanics.

References Powered by Scopus

Guidelines of care for the management of acne vulgaris

1138Citations
N/AReaders
Get full text

Comparison of the epidemiology of acne vulgaris among Caucasian, Asian, Continental Indian and African American women

143Citations
N/AReaders
Get full text

Microbiological profile of sarecycline, a novel targeted spectrum tetracycline for the treatment of acne vulgaris

62Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Sarecycline for moderate to severe acne: a promising narrow-spectrum antibacterial drug

0Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Moore, A. Y., Hurley, K., & Moore, S. A. (2023). A Post Hoc Analysis of Efficacy Data on Sarecycline in Hispanics with Acne from Two Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Clinical Trials. Antibiotics, 12(1). https://doi.org/10.3390/antibiotics12010089

Readers over time

‘23‘24‘2501234

Readers' Seniority

Tooltip

Lecturer / Post doc 1

50%

Researcher 1

50%

Readers' Discipline

Tooltip

Agricultural and Biological Sciences 1

50%

Pharmacology, Toxicology and Pharmaceut... 1

50%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1

Save time finding and organizing research with Mendeley

Sign up for free
0